SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, multiple severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
The highly transmissible Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
We present an interim analysis of a registered clinical study (NCT04800133) to establish
immunobridging with various antibody and cellular immunity markers and to compare the …
immunobridging with various antibody and cellular immunity markers and to compare the …
[HTML][HTML] Defending against SARS-CoV-2: The T cell perspective
P Almendro-Vázquez, R Laguna-Goya… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2-specific T cell response has been proven essential for viral clearance, COVID-
19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe …
19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe …
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
D Mrak, D Sieghart, E Simader, S Tobudic… - Nature …, 2022 - nature.com
Impaired response to COVID-19 vaccination is of particular concern in immunosuppressed
patients. To determine the best vaccination strategy for this vulnerable group we performed …
patients. To determine the best vaccination strategy for this vulnerable group we performed …
[PDF][PDF] Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Background Both infection and vaccination, alone or in combination, generate antibody and
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
N Le Bert, T Samandari - Cellular & Molecular Immunology, 2024 - nature.com
SARS-CoV-2 infections manifest with a broad spectrum of presentations, ranging from
asymptomatic infections to severe pneumonia and fatal outcomes. This review centers on …
asymptomatic infections to severe pneumonia and fatal outcomes. This review centers on …
[HTML][HTML] Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
Antibodies capable of neutralizing SARS-CoV-2 are well studied, but Fc receptor–
dependent antibody activities that can also significantly impact the course of infection have …
dependent antibody activities that can also significantly impact the course of infection have …
[HTML][HTML] Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …
T‐cell activation–induced marker assays in health and disease
C Poloni, C Schonhofer, S Ivison… - … and Cell Biology, 2023 - Wiley Online Library
Activation‐induced marker (AIM) assays have proven to be an accessible and rapid means
of antigen‐specific T‐cell detection. The method typically involves short‐term incubation of …
of antigen‐specific T‐cell detection. The method typically involves short‐term incubation of …